Cerebral microbleeds and blood pressure abnormalities in Parkinson's disease
- PMID: 29736422
- PMCID: PMC5933993
- DOI: 10.1016/j.ensci.2017.12.002
Cerebral microbleeds and blood pressure abnormalities in Parkinson's disease
Abstract
Blood pressure abnormalities are frequently observed in patients with Parkinson's disease (PD), and are associated with cerebrovascular diseases such as white matter hyperintensities and carotid atherosclerosis. We assessed the relationship between blood pressure abnormalities and cerebral microbleeds (CMBs), a marker of cerebral small vessel disease, in 128 patients with PD. We examined supine and orthostatic blood pressures and used 24-hour ambulatory blood pressure monitoring to assess the presence or absence of orthostatic hypotension (OH), supine hypertension (SH), nocturnal hypertension (NH), and loss of nocturnal blood pressure dips (non-dipping). CMBs were found in 13 (10.2%) patients, and the median number of CMBs was 1 (range: 1 to 10). Six of these patients had deep or infratentorial CMBs, six had strictly lobar CMBs, and one had mixed CMBs. Linear regression analysis indicated that presence of both OH and SH was independently associated with greater numbers of CMBs in deep or infratentorial regions, independent of age, sex, cardiovascular risk factors, and white matter hyperintensities. NH and non-dipping were not associated with CMBs in deep or infratentorial regions, and there was no association between blood pressure and CMBs in lobar regions. Our results suggest that the presence of both OH and SH may be related to deep or infratentorial CMBs in patients with PD.
Keywords: Autonomic dysfunction; Cerebral microbleeds; Orthostatic hypotension; Parkinson's disease; Supine hypertension.
Figures
Similar articles
-
The prevalence and risk factors of cerebral microbleeds in patients with Parkinson's disease.Parkinsonism Relat Disord. 2015 Sep;21(9):1076-81. doi: 10.1016/j.parkreldis.2015.06.019. Epub 2015 Jun 26. Parkinsonism Relat Disord. 2015. PMID: 26142208
-
The risk factors and pattern of cerebral microbleeds in Parkinson's disease.Int J Neurosci. 2017 Oct;127(10):909-914. doi: 10.1080/00207454.2017.1278590. Epub 2017 Jan 17. Int J Neurosci. 2017. PMID: 28051884
-
The presence of cerebral microbleeds is associated with cognitive impairment in Parkinson's disease.J Neurol Sci. 2018 Oct 15;393:39-44. doi: 10.1016/j.jns.2018.08.009. Epub 2018 Aug 8. J Neurol Sci. 2018. PMID: 30103062
-
Cardiovascular dysautonomia and cognition in Parkinson's Disease - a possible relationship.Neurol Neurochir Pol. 2021;55(6):525-535. doi: 10.5603/PJNNS.a2021.0040. Epub 2021 May 26. Neurol Neurochir Pol. 2021. PMID: 34037978 Review.
-
Abnormal circadian blood pressure regulation and cognitive impairment in α-synucleinopathies.Hypertens Res. 2022 Dec;45(12):1908-1917. doi: 10.1038/s41440-022-01032-w. Epub 2022 Sep 20. Hypertens Res. 2022. PMID: 36123397 Review.
Cited by
-
The impact of supine hypertension on target organ damage and survival in patients with synucleinopathies and neurogenic orthostatic hypotension.Parkinsonism Relat Disord. 2020 Jun;75:97-104. doi: 10.1016/j.parkreldis.2020.04.011. Epub 2020 May 18. Parkinsonism Relat Disord. 2020. PMID: 32516630 Free PMC article.
-
Iron deposition heterogeneity in extrapyramidal system assessed by quantitative susceptibility mapping in Parkinson's disease patients with type 2 diabetes mellitus.Front Aging Neurosci. 2022 Sep 13;14:975390. doi: 10.3389/fnagi.2022.975390. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36177478 Free PMC article.
-
Orthostatic hypotension and cerebral small vessel disease: A systematic review.J Cereb Blood Flow Metab. 2025 Jan;45(1):13-31. doi: 10.1177/0271678X241283226. Epub 2024 Sep 16. J Cereb Blood Flow Metab. 2025. PMID: 39283022 Free PMC article.
-
Blood Pressure Patterns in Patients with Parkinson's Disease: A Systematic Review.J Pers Med. 2021 Feb 15;11(2):129. doi: 10.3390/jpm11020129. J Pers Med. 2021. PMID: 33671878 Free PMC article. Review.
-
The absence of orthostatic heart rate increase is associated with cognitive impairment in Parkinson's disease.PLoS One. 2020 Oct 15;15(10):e0240491. doi: 10.1371/journal.pone.0240491. eCollection 2020. PLoS One. 2020. PMID: 33057432 Free PMC article.
References
-
- Espay A.J., LeWitt P.A., Hauser R.A. Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets. Lancet Neurol. 2016;15:954–966. - PubMed
-
- YS Oh., Kim J.S., Yang D.W. Nighttime blood pressure and white matter hyperintensities in patients with Parkinson disease. Chronobiol. Int. 2013;30:811–817. - PubMed
-
- Kim J.S., Oh Y.S., Lee K.S. Carotid artery thickening and neurocirculatory abnormalities in de novo Parkinson disease. J. Neural Transmission (Vienna) 2014;121:1259–1268. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources